Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.71
-0.08-4.47%
At close: Dec 15, 4:00 PM EST
$1.74
0.031.75%
After Hours: 6:59 PM EST
Comments
Loading...
Caribou Biosciences Analyst Ratings and Price Targets | NASDAQ:CRBU | Benzinga
Caribou Biosciences Inc has a consensus price target of $15.5 based on the ratings of 7 analysts. The high is $32 issued by Oppenheimer on March 10, 2023. The low is $8 issued by Citigroup on November 3, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Citigroup, and HC Wainwright & Co. on November 5, 2025, November 3, 2025, and April 28, 2025, respectively. With an average price target of $6.67 between HC Wainwright & Co., Citigroup, and HC Wainwright & Co., there's an implied 283.14% upside for Caribou Biosciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Citigroup
B of A Securities
RBC Capital
Truist Securities
1calculated from analyst ratings
Analyst Ratings for Caribou Biosciences
FAQ
What is the target price for Caribou Biosciences (CRBU) stock?
The latest price target for Caribou Biosciences (NASDAQ:CRBU) was reported by HC Wainwright & Co. on November 5, 2025. The analyst firm set a price target for $9.00 expecting CRBU to rise to within 12 months (a possible 417.24% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Caribou Biosciences (CRBU)?
The latest analyst rating for Caribou Biosciences (NASDAQ:CRBU) was provided by HC Wainwright & Co., and Caribou Biosciences maintained their buy rating.
When was the last upgrade for Caribou Biosciences (CRBU)?
There is no last upgrade for Caribou Biosciences
When was the last downgrade for Caribou Biosciences (CRBU)?
There is no last downgrade for Caribou Biosciences.
When is the next analyst rating going to be posted or updated for Caribou Biosciences (CRBU)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Caribou Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Caribou Biosciences was filed on November 5, 2025 so you should expect the next rating to be made available sometime around November 5, 2026.
Is the Analyst Rating Caribou Biosciences (CRBU) correct?
While ratings are subjective and will change, the latest Caribou Biosciences (CRBU) rating was a maintained with a price target of $3.00 to $9.00. The current price Caribou Biosciences (CRBU) is trading at is $1.74, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
